M-A | Novos agentes farmacológicos (ditanos e gepantos) não são tão bons quanto os triptanos no tratamento da enxaqueca.
13 Out, 2021 | 13:10hComentário: Migraine: Older Drugs May Be Best Bet for Lessening Pain – Physician’s Weekly
Comentário no Twitter
This systematic review and meta-analysis found that ditans and gepants were associated with less efficacy compared with triptans, whereas gepants were associated with fewer adverse events compared with triptans for migraine treatment. https://t.co/PFCHg4MZ8r
— JAMA Network Open (@JAMANetworkOpen) October 11, 2021


